stockrowTenet Healthcare Corporation
THC Healthcare Medical Care Facilities
Tenet Healthcare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $21.3 billion, up 3.07% from fiscal 2024.
- Revenue
- +6.47%
- EPS
- +291.1%
- Free cash flow
- +39.2%
- Total debt
- +0.42%
Quarter to September 2026, against a year earlier
Follow THC
Alert me
Tenet Healthcare Corporation (THC) Return on equity
Tenet Healthcare Corporation's return on equity over the twelve months to 30 September 2026 was 43.9%, up 20.2 percentage points from fiscal 2025 (23.8%). Over the past ten years it has ranged from −86.9% (fiscal 2017) to 71.6% (fiscal 2024); the current reading is higher than 73% of that period. That is above the Medical Care Facilities industry median of 5.03% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 23.8% | (47.84) |
| FY2024 | 71.6% | 49.69 |
| FY2023 | 21.9% | 3.71 |
| FY2022 | 18.2% | (42.91) |
| FY2021 | 61.1% | 3.04 |
| FY2020 | 58.1% | 96.34 |
| FY2019 | −38.3% | (55.23) |
| FY2018 | 17.0% | 103.83 |
| FY2017 | −86.9% | (68.04) |
| FY2016 | −18.8% | (2.76) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| CON Concentra Group Holdings Parent, Inc. compare | 47.9% |
| THC Tenet Healthcare Corporation | 43.9% |
| UHS Universal Health Services, Inc. compare | 40.0% |
| CHE Chemed Corporation compare | 29.1% |
| PACS PACS Group, Inc. compare | 26.5% |
| EHC Encompass Health Corporation compare | 19.4% |
| ENSG The Ensign Group, Inc. compare | 17.0% |
| FMS Fresenius Medical Care AG & Co. KGaA compare | 5.90% |
| DVA DaVita Inc. compare | −277.7% |
| Medical Care Facilities industry median | 5.03% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on THC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement